Investor Shendelman Shoshana
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Shendelman Shoshana . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-08-14 13D/A APLT / Applied Therapeutics, Inc. 8,646,891 7,803,355
2024-03-05 13D/A APLT / Applied Therapeutics, Inc. 8,080,945 8,646,891
2023-11-13 13D/A APLT / Applied Therapeutics, Inc. 8,075,377 8,080,945
2023-04-28 13D/A APLT / Applied Therapeutics, Inc. 7,570,835 8,075,377
2022-10-14 13D/A APLT / Applied Therapeutics, Inc. 7,182,556 7,570,835
2022-01-28 13D/A APLT / Applied Therapeutics, Inc. 6,654,266 7,182,556
2021-04-16 13D/A APLT / Applied Therapeutics, Inc. 6,336,057 6,654,266
2020-08-14 13D/A APLT / Applied Therapeutics, Inc. 6,394,084 6,336,057
2020-06-01 13D/A APLT / Applied Therapeutics, Inc. 5,793,338 6,394,084
2019-05-29 13D APLT / Applied Therapeutics, Inc. 5,793,338